Synthesis, biological evaluation and preliminary mechanisms of 6-amino substituted harmine derivatives as potential antitumor agents

被引:9
作者
Hu, Dongyan [1 ,2 ]
Han, Guangtian [2 ]
Ren, Huazhong [2 ]
Li, Xinwei [3 ]
Li, Xi'an [2 ]
Yue, Lirong [2 ]
Xu, Jiao [2 ]
Feng, Jiafu [2 ]
Guo, Li [1 ]
机构
[1] Chengdu Univ Tradit Chinese Med, Pharm Coll, Chengdu 611137, Peoples R China
[2] Leshan Vocat & Tech Coll, Genuine Med Mat Engn Res Ctr Leshan, Dept Pharm, Leshan 614000, Peoples R China
[3] Guangxi Normal Univ, Sch Chem & Pharmaceut Sci, Guilin 541004, Peoples R China
关键词
-Carbolines; Harmine; Antitumor activity; Structural modification; TOPOISOMERASE-I INHIBITION; CARBOLINE DERIVATIVES; BINDING PROPERTIES; BETA-CARBOLINES; CELL-CYCLE; ANTICANCER; VITRO; CYTOTOXICITY; APOPTOSIS; PROLIFERATION;
D O I
10.1016/j.fitote.2022.105329
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
To explore the effect of the introduction of the amino and substituted amino groups on the antitumor activity of harmine, twenty-five novel 6-amino substituted harmine derivatives (3a-3j and 5a-5o) were synthesized and evaluated for anti-proliferative activity on a panel of cancer cell lines. Compounds 3i and 5n exhibited the most potent antiproliferative activity with IC50 values lower than 2.2 mu M. Especially, compound 5n possessed extremely potent antitumor activity with IC50 values of 0.34 mu M and 0.65 mu M against HL-60 and A549 cell lines, respectively. Further, the preliminary studies of mechanisms showed that compound 5n could significantly induce cell apoptosis in a dose-dependent manner, cause cell cycle arrest at the G2/M phase and intercalate into ct-DNA via the competition with EB, while displaying very weak topoisomerase I (Topo I) inhibition activity. More importantly, 5n showed mild cytotoxicity against human normal lung epithelial cells BEAS-2B. Based on these considerations, 5n may be a good antitumor candidate compound for further exploration.
引用
收藏
页数:11
相关论文
共 55 条
[1]   Recent Developments on Synthesis Strategies, SAR Studies and Biological Activities of β-Carboline Derivatives-An Update [J].
Abinaya, Ramanjulu ;
Srinath, Santhanam ;
Soundarya, S. ;
Sridhar, Radhakrishnan ;
Balasubramanian, Kalpattu Kuppusamy ;
Baskar, Baburaj .
JOURNAL OF MOLECULAR STRUCTURE, 2022, 1261
[2]   Platinum Compounds: A Hope for Future Cancer Chemotherapy [J].
Ali, Imran ;
Wani, Waseem A. ;
Saleem, Kishwar ;
Haque, Ashanul .
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2013, 13 (02) :296-306
[3]   The discovery of tetrahydro-β-carbolines as inhibitors of the kinesin Eg5 [J].
Barsanti, Paul A. ;
Wang, Weibo ;
Ni, Zhi-Jie ;
Duhl, David ;
Brammeier, Nathan ;
Martin, Eric ;
Bussiere, Dirksen ;
Walter, Annette O. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (01) :157-160
[4]   DNA binding properties of 9-substituted harmine derivatives [J].
Cao, RH ;
Peng, WL ;
Chen, HS ;
Ma, Y ;
Liu, XD ;
Hou, XR ;
Guan, HJ ;
Xu, AL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 338 (03) :1557-1563
[5]   β-Carboline alkaloids:: Biochemical and pharmacological functions [J].
Cao, Rihui ;
Peng, Wenlie ;
Wang, Zihou ;
Xu, Anlong .
CURRENT MEDICINAL CHEMISTRY, 2007, 14 (04) :479-500
[6]   Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: Implications for coagulation events and antigenic spread in systemic lupus erythematosus [J].
CasciolaRosen, L ;
Rosen, A ;
Petri, M ;
Schlissel, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (04) :1624-1629
[7]   Novel IKK inhibitors:: β-carbolines [J].
Castro, AC ;
Dang, LC ;
Soucy, F ;
Grenier, L ;
Mazdiyasni, H ;
Hottelet, M ;
Parent, L ;
Pien, C ;
Palombella, V ;
Adams, J .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (14) :2419-2422
[8]   Synthesis and cytotoxicity evaluation of 4′-amino-4′-dehydroxyloleandrin derivatives [J].
Chen, Hu ;
Lei, Min ;
Ma, Biao ;
Liu, Miao ;
Guo, Dean ;
Liu, Xuan ;
Hu, Lihong .
FITOTERAPIA, 2016, 113 :85-90
[9]   Insights into drug discovery from natural products through structural modification [J].
Chen, Jichao ;
Li, Wenlong ;
Yao, Hequan ;
Xu, Jinyi .
FITOTERAPIA, 2015, 103 :231-241
[10]   Enhancing global access to cancer medicines [J].
Cortes, Javier ;
Perez-Garcia, Jose Manuel ;
Llombart-Cussac, Antonio ;
Curigliano, Giuseppe ;
El Saghir, Nagi S. ;
Cardoso, Fatima ;
Barrios, Carlos H. ;
Wagle, Shama ;
Roman, Javier ;
Harbeck, Nadia ;
Eniu, Alexandru ;
Kaufman, Peter A. ;
Tabernero, Josep ;
Garcia-Estevez, Laura ;
Schmid, Peter ;
Arribas, Joaquin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2020, 70 (02) :105-124